# A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

> **NCT03101293** · PHASE1 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-831

## Key facts

- **NCT ID:** NCT03101293
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2017-05-19
- **Final completion:** 2017-05-26
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101293, "A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03101293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*